TREM-1 - a New Marker of Serious Infectious Complications in Colorectal Surgery?

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions
Colorectal (Colon or Rectal) Cancer
Interventions
DIAGNOSTIC_TEST

TREM-1

The TREM-1 (triggering receptor expressed on myeloid cells-1) glycoprotein is a receptor involved in the activation of monocytes and neutrophils during the inflammatory process. There are many reports indicating the soluble form of this receptor is a reliable diagnostic marker of infection and inflammatory response induced by trauma. Therefore the investigators aimed to investigate the potential use of soluble TREM-1 to predict serious infectious complications in patients undergoing laparoscopic colorectal surgery.Blood samples were drawn four times: on the day of surgery (preoperatively) and on the three following postoperative days (PODs).

Trial Locations (1)

30-688

Jagiellonian University Medical College, Krakow

All Listed Sponsors
lead

Jagiellonian University

OTHER

NCT05933408 - TREM-1 - a New Marker of Serious Infectious Complications in Colorectal Surgery? | Biotech Hunter | Biotech Hunter